The Opioid Receptors and their Ligands

  • Lars Terenius
Part of the Published Nobel Symposia book series (NOFS, volume 42)


The term opioid is used to describe a morphine-like compound. Typical morphine-like activity includes analgesia, drowsiness, changes in mood and mental clouding (10). Several thousand compounds share these properties of morphine and it is clear that they have a very specific action profile. It is therefore logical to assume that they react with a common, specific receptor. In recent years, however, it has become obvious that subgroups of opioids and opioid receptors must be considered. One particularly interesting subgroup is represented by the endogenous morphine-like substances, the endorphins, which are peptides. It is the purpose of this communication to review studies on opioid receptor heterogeneity .


Opioid Receptor Opioid System Receptor Selectivity Endogenous Agonist Narcotic Antagonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Beckett, A.H. and A.F. Casy. J. Pharm. Pharmacol. 6:986–999, 1954.PubMedCrossRefGoogle Scholar
  2. 2.
    Belluzzi, J.D., N. Grant, V. Garsky, D. Sarantakis, C.D. Wise and L. Stein. Nature (London) 260:625–626, 1976.CrossRefGoogle Scholar
  3. 3.
    Bloom, F., E. Battenberg, J. Rossier, N. Ling and R. Guillemin. Proc. Natl. Acad. Sci. USA 75:1591–1595, 1978.PubMedCrossRefGoogle Scholar
  4. 4.
    Büscher, H.H., R.C. Hill, D. Römer, F. Cardinaux, A. Closse, D. Hauser and J. Pless. Nature (London) 261:423–425, 1976.CrossRefGoogle Scholar
  5. 5.
    Carlsson, A. In: Pre- and Postsynaptic Receptors, edited by E. Usdin and W.E. Bunney Jr. New York: Marcel Dekker, 1975.Google Scholar
  6. 6.
    Changeux, J.-P. In: Handbook of Psychopharmacology, vol. 6: Biogenic Amine Receptors, edited by L.L. Iversen, S.D. Iversen and S.H. Snyder. New York: Plenum Press, 1975, p. 235–301.Google Scholar
  7. 7.
    Della Bella, D., F. Casacci and A. Sassi. In: Advances in Biochemical Psychopharmacology, vol. 18, edited by E. Costa and M. Trabucchi. New York: Raven Press, 1978, p. 271–277.Google Scholar
  8. 8.
    Dutta, A.S., J.J. Gormley, C.F. Hayward, J.S. Morley, J.S. Shaw, G.J. Stacey and M.J. Turnbull. Br. J. Pharmacol. 61:481P-482P.Google Scholar
  9. 9.
    Goldstein, A. Science 193:1081–1086, 1976.PubMedCrossRefGoogle Scholar
  10. 10.
    Goodman, L.S. and A. Gilman (editors). The Pharmacological Basis of Therapeutics (5th ed.). New York: Macmillan Publ. Co., 1975.Google Scholar
  11. 11.
    Gráf, L., J.I. Szekely, A.Z. Ronai, Z. Dunai-Kovacs and S. Bajusz. Nature (London) 263:240–241, 1976.CrossRefGoogle Scholar
  12. 12.
    Greengard, P. Nature (London) 260:101–108, 1976.CrossRefGoogle Scholar
  13. 13.
    Gunne, L.-M., L. Lindström and L. Terenius. J. Neural Transm. 40:13–19, 1977.PubMedCrossRefGoogle Scholar
  14. 14.
    Hughes, J. and H.W. Kosterlitz. Br. Med. Bull. 33:157–161, 1977.PubMedGoogle Scholar
  15. 15.
    Lewis, J.W., K.W. Bentley and A. Cowan. Ann. Rev. Pharmacol. 11:241–270, 1971.PubMedCrossRefGoogle Scholar
  16. 16.
    Lord, J.A.H., A.A. Waterfield, J. Hughes and H.W. Kosterlitz. Nature (London) 267:495–499, 1977.CrossRefGoogle Scholar
  17. 17.
    Martin, W.R. Pharmacol. Rev. 19:464–521, 1967.Google Scholar
  18. 18.
    Martin, W.R. Fed. Proc. 29:13–18, 1970.PubMedGoogle Scholar
  19. 19.
    Martin, W.R., C.G. Eades, J.A. Thompson, R.E. Huppler and P.E. Gilberg. J. Pharmacol. Exp. Ther. 197:517–532, 1976.PubMedGoogle Scholar
  20. 20.
    Palmour, R.M. , F.R. Ervin, H. Wagemaker and R. Cade. In: Endorphins in Mental Illness, edited by E. Usdin and W.E. Bunney Jr. London: McMillan, 1978, in press.Google Scholar
  21. 21.
    Pearse, A.G.E. Nature (London) 262:92–94, 1976.CrossRefGoogle Scholar
  22. 22.
    Pert, C.B. and S.H. Snyder. Mol. Pharmacol. 10:868–879, 1974.Google Scholar
  23. 23.
    Portoghese, P.S. Acc. Chem. Res. 11:21–29, 1978.CrossRefGoogle Scholar
  24. 24.
    Rossier, J., T.M. Vargo, S. Minick, N. Ling, F.E. Bloom and R. Guillemin. Proc. Natl. Acad. Sci. USA 74:5162–5165, 1977.PubMedCrossRefGoogle Scholar
  25. 25.
    Römer, D., H.H. Büscher, R.C. Hill, J. Pless, W. Bauer, F. Cardinaux, A. Closse, D. Hauser and R. Huguenin. Nature (London) 268:547–549, 1977.CrossRefGoogle Scholar
  26. 26.
    Schild, H.O. Br. J. Pharmacol. 2:189–206, 1947.Google Scholar
  27. 27.
    Schultzberg, M., T. Hökfelt, J.M. Lundberg, L. Terenius, L.G. Elfvin and R. Elde. Acta physiol. scand., in press, 1978.Google Scholar
  28. 28.
    Sharma, S.K., M. Nirenberg and W.A. Klee. Proc. Natl. Acad. Sci. USA 72:590–599, 1975.PubMedCrossRefGoogle Scholar
  29. 29.
    Simon, E.J. and J.M. Hiller. Ann. Rev. Pharmacol. 18:371–394, 1978.CrossRefGoogle Scholar
  30. 30.
    Smith, A.A., R. Albin and M. Crofford. In: Opiates and Endogenous Opioid Peptides, edited by H.W. Kosterlitz. Amsterdam: Elsevier/North Holland, 1976, p. 289–294.Google Scholar
  31. 31.
    Smits, S.E. and A.E. Takemori. Br. J. Pharmacol. 39:627–638, 1970.PubMedGoogle Scholar
  32. 32.
    Terenius, L. Psychoneuroendocrinology 2:53–58, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Terenius, L. Ann. Rev. Pharmacol. 18:189–204, 1978.CrossRefGoogle Scholar
  34. 34.
    Terenius, L. and A. Wahlström. Life Sci. 16:1759–1764, 1975.CrossRefGoogle Scholar
  35. 35.
    Terenius, L. and A. Wahlström. Eur. J. Pharmacol. 40:241–248, 1976.PubMedCrossRefGoogle Scholar
  36. 36.
    Terenius, L., A. Wahlström, L. Lindström and E. Widerlöv. Neuroscience Letters 3:157–162, 1976.PubMedCrossRefGoogle Scholar
  37. 37.
    Traber, J., K. Fischer, S. Latzin and B. Hamprecht. FEBS Lett. 49:260–263, 1974.PubMedCrossRefGoogle Scholar
  38. 38.
    Wahlström, A., M. Brandt, L. Moroder, E. Wünsch, G. Lindeberg, U. Ragnarsson, L. Terenius and B. Hamprecht. FEBS Lett. 77:28–32, 1977.PubMedCrossRefGoogle Scholar
  39. 39.
    Watson, S.J., J.D. Barchas and C.H. Li. Proc. Natl. Acad. Sci. USA 74:5155–5158, 1977.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • Lars Terenius
    • 1
  1. 1.Department of PharmacologyUniversity of UppsalaUppsalaSweden

Personalised recommendations